Skip to content

VISTAGEN THERAPEUTICS, INC.: filings

Every VISTAGEN THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q1 202736740001628280-26-057116
10-K2026-06-15fiscal FY 202640800001628280-26-043271
10-Q2026-02-12fiscal Q3 2026361080001628280-26-007718
10-Q2025-11-13fiscal Q2 2026361040001628280-25-052079
10-Q2025-08-07fiscal Q1 202636740001411685-25-000064
10-K2025-06-17fiscal FY 202538760001411685-25-000041
10-Q2025-02-13fiscal Q3 2025341020001411685-25-000019
10-Q2024-11-07fiscal Q2 202534980001411685-24-000048
10-Q2024-08-13fiscal Q1 202534700001411685-24-000037
10-K2024-06-11fiscal FY 202436720001411685-24-000022
10-Q2024-02-13fiscal Q3 202427820001437749-24-003916
10-Q2023-11-09fiscal Q2 202427780001437749-23-031293
10-Q2023-08-10fiscal Q1 202432660001437749-23-023127
10-K2023-06-28fiscal FY 2023341530001437749-23-018793
10-Q2023-02-07fiscal Q3 2022341000001851734-23-000035
10-Q2022-11-10fiscal Q2 202234960001851734-22-000662
10-Q2022-08-11fiscal Q1 202234700001851734-22-000432
10-K2022-06-23fiscal FY 2022381200001851734-22-000349
10-Q2022-02-10fiscal Q3 202233960001437749-22-003009
10-Q2021-11-10fiscal Q2 202233940001437749-21-026161
10-Q2021-08-12fiscal Q1 202132680001654954-21-008845
10-K2021-06-29fiscal FY 2021331400001654954-21-007380
10-Q2021-02-11fiscal Q3 202130880001654954-21-001538
10-Q2020-11-12fiscal Q2 202130840001654954-20-012266
10-Q2020-08-13fiscal Q1 202129620001654954-20-009069
10-K2020-06-29fiscal FY 2020321290001654954-20-007107
10-Q2020-02-13fiscal Q3 202030870001654954-20-001517
10-Q2019-11-07fiscal Q2 202030830001654954-19-012431
10-Q2019-08-13fiscal Q1 202028590001654954-19-009386
10-K2019-06-25fiscal FY 2019311360001654954-19-007632
10-Q2019-02-12fiscal Q3 201928740001654954-19-001372
10-Q2018-10-29fiscal Q2 201928740001654954-18-011665
10-Q2018-08-14fiscal Q1 201927560001654954-18-009096
10-K2018-06-26fiscal FY 2018301380001654954-18-006990
10-Q2018-02-12fiscal Q3 201826720001654954-18-001360
10-Q2017-11-09fiscal Q2 201825680001654954-17-010318
10-Q2017-08-14fiscal Q1 201825520001654954-17-007550
10-K2017-06-29fiscal FY 2017311480001654954-17-005976
10-Q2017-02-13fiscal Q3 201628800001654954-17-001004
10-Q2016-11-14fiscal Q2 201626700001415889-16-007413
10-Q2016-08-12fiscal Q1 201626540001415889-16-006799
10-K2016-06-24fiscal FY 2016331400001415889-16-006331
10-Q2016-02-16fiscal Q3 201629800001415889-16-004781
10-Q2015-11-16fiscal Q2 201628780001415889-15-003716
10-Q2015-08-14fiscal Q1 201624490001415889-15-002728
10-K2015-06-29fiscal FY 2015341410001415889-15-002221
10-Q2015-02-17fiscal Q3 201532880001415889-15-000568
10-Q2014-11-19fiscal Q2 201431850001415889-14-003624
10-Q2014-08-12fiscal Q1 201431680001415889-14-002406
10-K2014-06-25fiscal FY 2014371430001415889-14-001957
10-Q2014-02-14fiscal Q3 2013331070001415889-14-000587
10-Q2013-11-14fiscal Q2 201328820001415889-13-002318
10-Q2013-08-14fiscal Q1 201332770001415889-13-001620
10-K2013-07-18fiscal FY 2012311750001415889-13-001409
10-Q2013-02-14fiscal Q3 201230870001415889-13-000263
10-Q2012-11-14fiscal Q2 201230940001415889-12-001683
10-Q2012-08-14fiscal Q1 201230720001415889-12-001223
10-K2012-07-02fiscal FY 201129950001415889-12-000973
10-Q2012-02-14fiscal Q3 201130970001415889-12-000216
10-Q2011-11-14fiscal Q2 201130970001415889-11-001247
10-Q2011-08-22fiscal Q1 201130720001415889-11-000833

Inspect the source

Entity
VISTAGEN THERAPEUTICS, INC. / CIK 0001411685
Captured
2026-09-20T08:01:56.841Z
SEC response SHA-256
1d0d09c7b53b173e35f99fba8d3201ca751174b9bb70167acdba04307bebca91

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411685.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))